Atorvastatin reduced coronary and stroke events in patients with hypertension and without dyslipidemia: COMMENTARY
- Miracle or mirage? Learner, Sue // Nursing Standard;8/1/2007, Vol. 21 Issue 47, p18
More than two million people in the UK are taking statins to reduce their cholesterol. But some doctors claim that they can cause affective disorders.
- Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial--Lipid Lowering Arm (ASCOT-LLA): a multicentre rando... // Current Medical Literature: Stroke Review;2003, Vol. 7 Issue 3, p85
Reports on a study which set out to assess the benefits of cholesterol lowering in the primary prevention of coronary heart disease in hypertensive patients who are not conventionally deemed dyslipidemic. Reduction in major end points with atorvastatin; Need for a radical rethink on the...
- The National Cholesterol Eduction Program. Cleeman, James I.; Lenfant, Claude // JAMA: Journal of the American Medical Association;12/23/98-12/30/98, Vol. 280 Issue 24, p2099
Discusses the National Cholesterol Education Program (NCEP) from the United States National Heart, Lung, and Blood Institute. Efforts to promote improved prevention and treatment of cardiovascular disease; Clinical trails which have provided conclusive evidence for the benefits of cholesterol...
- Coronary Prevention Group calls for cholesterol testing for all. // BMJ: British Medical Journal (International Edition);3/4/89, Vol. 298 Issue 6673, p552
Reports the call of Coronary Prevention Group for cholesterol testing in Great Britain. Strategy of preventing coronary heart disease; Need for assessment of risk factors of the disease; Advice for patients with high cholesterol concentrations.
- Knowledge assessment regarding secondary prevention of coronary heart disease- a multi centre survey. Matthias, Anne Thushara; Lokunarangoda, Niroshan C.; Ekanayaka, Ruvan // BMC Medical Education;2014, Vol. 14 Issue 1, p1
Background Cardiovascular Disease (CVD) is a major cause of mortality worldwide. Control and reduction of cardiovascular risk factors such as elevated blood pressure, high cholesterol levels, excess of body weight, smoking and lack of exercise can contribute to a reduction of CVD mortality....
- The role of Coenzyme Q10 in statin-associated myopathy. Kalra, Sanjay; Agrawal, Navneet; Kalra, Bharti; Sharma, Amit; Kamboj, Ritu // Electronic Physician;2009, Vol. 1, p2
Statins, or 3-hydroxyl-3-methylglutaryl coenzyme HMG-CoA reductase inhibitors, are cholesterol-lowering drugs which are frequently used in the primary and secondary prevention of coronary artery disease. Current research and recommendations support and encourage more extensive use of these...
- Patients 'exercise' their right to manage cholesterol. Petersen, Carolyn // Managed Healthcare;Jan1999, Vol. 9 Issue 1, p52
Focuses on an alternative approach in managing the cost of high cholesterol in the United States. Blood cholesterol level management as one way of reducing the incidence of coronary heart disease (CHD); Cost-effectiveness of various dosages of a single therapeutic; Exercise as an important key...
- Prospects for preventing heart disease: Population based approaches offer a cost effective way of reducing risk. Leeder, Stephen; Gliksman, Michael // BMJ: British Medical Journal (International Edition);11/3/90, Vol. 301 Issue 6759, p1004
Focuses on the preventive measures for coronary heart disease. Evaluation of mortality rate caused by the disease; Measurement of blood pressure and total serum cholesterol concentration; Contribution of cigarette smoking on the development of the disease.
- Lower patients' cholesterol now. Oliver, Michael; Poole-Wilson, Philip // BMJ: British Medical Journal (International Edition);5/20/95, Vol. 310 Issue 6990, p1280
Presents clinical trial evidence to the principle that the risk of coronary heart disease and total mortality can be reduced by lowering plasma cholesterol concentrations. Principles of lipid hypothesis; Questions on cholesterol reduction; Favorable results from scandinavian studies on...